Picture of Sanofi SA logo

SAN — Sanofi SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season

BRIEF-Sanofi Spokesperson Says Nuvaxovid to Be Available Across U.S. for 2026-27 Respiratory Virus Season

- Sanofi Spokesperson:

  • NUVAXOVID WILL BE AVAILABLE ACROSS U.S. FOR THE 2026-2027 RESPIRATORY VIRUS SEASON- SANOFI SPOKESPERSON

  • WELCOME APPROVAL OF UPDATED FORMULATION OF NUVAXOVID FOR USE DURING 2026-2027 RESPIRATORY VIRUS SEASON - SANOFI SPOKESPERSON

Source text: [ID:]

Further company coverage: SASY.PA


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Sanofi SA

See all news